Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	cell morphogenesis	TANC2 DIP2B DACT2 DOCK10 APC LAMA3 CDH23 NCAM1 CLASP2 ITGA4 MED1 ECT2 PREX2 FRY FAT1 EFNA2 SIPA1L1 MYPN PTPRQ CNTNAP2 AHR BAIAP2 MARK2 PALLD SOS1	2.40e-06	1194	153	25	GO:0000902
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	TANC2 DIP2B DOCK10 APC LAMA3 CDH23 NCAM1 CLASP2 ITGA4 PREX2 EFNA2 SIPA1L1 MYPN PTPRQ CNTNAP2 BAIAP2 MARK2 PALLD SOS1	2.95e-06	748	153	19	GO:0048667
GeneOntologyBiologicalProcess	positive regulation of termination of DNA-templated transcription	SETX WNK1	5.47e-05	2	153	2	GO:0060566
GeneOntologyBiologicalProcess	positive regulation of termination of RNA polymerase II transcription	SETX WNK1	5.47e-05	2	153	2	GO:1904595
GeneOntologyBiologicalProcess	neuron development	TANC2 DIP2B FAT4 SETX DOCK10 APC RAP1GAP2 LAMA3 CDH23 NCAM1 CLASP2 ITGA4 WNK1 PREX2 FARP2 FRY EFNA2 SIPA1L1 MYPN PTPRQ CNTNAP2 BAIAP2 MARK2 PALLD SOS1	7.48e-05	1463	153	25	GO:0048666
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	FAT4 PCDHGB1 PCDHGA5 CDH23 FAT1 MYPN PKD1 PALLD	7.94e-05	187	153	8	GO:0007156
GeneOntologyBiologicalProcess	axonogenesis	DIP2B APC LAMA3 NCAM1 CLASP2 ITGA4 EFNA2 SIPA1L1 MYPN CNTNAP2 BAIAP2 MARK2 PALLD SOS1	8.50e-05	566	153	14	GO:0007409
GeneOntologyBiologicalProcess	neuron projection morphogenesis	TANC2 DIP2B DOCK10 APC LAMA3 NCAM1 CLASP2 ITGA4 PREX2 EFNA2 SIPA1L1 MYPN CNTNAP2 BAIAP2 MARK2 PALLD SOS1	9.83e-05	802	153	17	GO:0048812
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	FAT4 PCDHGB1 PCDHGA5 CDH23 ITGA4 WNK1 FAT1 MYPN PKD1 PALLD	1.19e-04	313	153	10	GO:0098742
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	TANC2 DIP2B DOCK10 APC LAMA3 NCAM1 CLASP2 ITGA4 PREX2 EFNA2 SIPA1L1 MYPN CNTNAP2 BAIAP2 MARK2 PALLD SOS1	1.26e-04	819	153	17	GO:0120039
GeneOntologyBiologicalProcess	cell projection morphogenesis	TANC2 DIP2B DOCK10 APC LAMA3 NCAM1 CLASP2 ITGA4 PREX2 EFNA2 SIPA1L1 MYPN CNTNAP2 BAIAP2 MARK2 PALLD SOS1	1.40e-04	826	153	17	GO:0048858
GeneOntologyBiologicalProcess	cell-cell adhesion	FAT4 ZNF609 PCDHGB1 NT5E PCDHGA5 LAMA3 CDH23 NCAM1 ITGA4 ITGA9 WNK1 TBX18 STK10 FAT1 ZNF608 MYPN PKD1 BAIAP2 PALLD MEGF11	1.42e-04	1077	153	20	GO:0098609
GeneOntologyBiologicalProcess	regulation of organelle organization	TBC1D19 SYNPO2 BCL7B APC CLASP2 ECT2 DCTN1 C2CD5 USP10 VPS13D TBC1D4 SIPA1L1 PRKAA1 BUB1 PKD1 ATF7IP2 FBXO43 SASS6 PLA2G4A MEIOSIN BAIAP2 MARK2 PAN3	1.44e-04	1342	153	23	GO:0033043
GeneOntologyBiologicalProcess	maltose metabolic process	MGAM GAA	1.63e-04	3	153	2	GO:0000023
GeneOntologyBiologicalProcess	neuron projection development	TANC2 DIP2B FAT4 SETX DOCK10 APC RAP1GAP2 LAMA3 CDH23 NCAM1 CLASP2 ITGA4 PREX2 FRY EFNA2 SIPA1L1 MYPN CNTNAP2 BAIAP2 MARK2 PALLD SOS1	2.07e-04	1285	153	22	GO:0031175
GeneOntologyCellularComponent	axon	TANC2 ATP5MC1 DIP2B SETX MYO1D PCDHGB1 APC NCAM1 CLASP2 ITGA4 OPN1SW DCTN1 PGR CACNG2 MYPN PRKAA1 CNTNAP2 TNK2 USH2A PALLD	1.01e-05	891	155	20	GO:0030424
GeneOntologyCellularComponent	somatodendritic compartment	TANC2 ATP5MC1 DIP2B MYO1D FXR2 DOCK10 APC NCAM1 ITGA4 DCTN1 PGR CACNG2 EFNA2 SIPA1L1 PRKAA1 CNTNAP2 SKOR1 TNK2 BAIAP2 MARK2 USH2A PALLD SOS1	3.78e-05	1228	155	23	GO:0036477
GeneOntologyCellularComponent	neuronal cell body	ATP5MC1 DIP2B MYO1D APC NCAM1 ITGA4 DCTN1 PGR EFNA2 SIPA1L1 PRKAA1 CNTNAP2 SKOR1 TNK2 BAIAP2 USH2A PALLD SOS1	4.89e-05	835	155	18	GO:0043025
GeneOntologyCellularComponent	cell body	ATP5MC1 DIP2B MYO1D APC NCAM1 ITGA4 OPN1SW DCTN1 PGR EFNA2 SIPA1L1 PRKAA1 CNTNAP2 SKOR1 TNK2 BAIAP2 USH2A PALLD SOS1	6.03e-05	929	155	19	GO:0044297
GeneOntologyCellularComponent	distal axon	ATP5MC1 SETX PCDHGB1 APC NCAM1 CLASP2 ITGA4 OPN1SW PGR TNK2 USH2A PALLD	1.01e-04	435	155	12	GO:0150034
GeneOntologyCellularComponent	site of polarized growth	SETX PCDHGB1 APC NCAM1 CLASP2 ITGA4 FRY TNK2 PALLD	1.17e-04	253	155	9	GO:0030427
GeneOntologyCellularComponent	cation channel complex	ATP5MC1 CACHD1 CACNG2 PKD1 CNTNAP2 C2CD6 KCNMB3 ATP5F1B	3.78e-04	235	155	8	GO:0034703
GeneOntologyCellularComponent	growth cone	SETX PCDHGB1 APC NCAM1 CLASP2 ITGA4 TNK2 PALLD	4.98e-04	245	155	8	GO:0030426
GeneOntologyCellularComponent	basal cortex	CLASP2 MARK2	1.12e-03	7	155	2	GO:0045180
GeneOntologyCellularComponent	actin-based cell projection	ATP6V1B2 MYO1D CDH23 FAT1 PTPRQ BAIAP2 USH2A PALLD	1.13e-03	278	155	8	GO:0098858
Domain	LAM_G_DOMAIN	FAT4 LAMA3 FAT1 CNTNAP2 USH2A	1.27e-05	38	150	5	PS50025
Domain	Laminin_G_2	FAT4 LAMA3 FAT1 CNTNAP2 USH2A	1.64e-05	40	150	5	PF02210
Domain	LamG	FAT4 LAMA3 FAT1 CNTNAP2 USH2A	2.64e-05	44	150	5	SM00282
Domain	Laminin_G	FAT4 LAMA3 FAT1 CNTNAP2 USH2A	1.02e-04	58	150	5	IPR001791
Domain	GDS_CDC24_CS	ECT2 PREX2 FARP2 SOS1	2.64e-04	39	150	4	IPR001331
Domain	C2_dom	PLCZ1 INPP4A C2CD5 PLA2G4A C2CD6 SEC63 TNS1	3.64e-04	164	150	7	IPR000008
Domain	Glyco_hydro_31_CS	MGAM GAA	3.80e-04	4	150	2	IPR030459
Domain	Gal_mutarotase_N	MGAM GAA	3.80e-04	4	150	2	IPR031727
Domain	NtCtMGAM_N	MGAM GAA	3.80e-04	4	150	2	PF16863
Domain	ATP_synth_asu_C	ATP6V1B2 ATP5F1B	6.31e-04	5	150	2	IPR000793
Domain	GLYCOSYL_HYDROL_F31_2	MGAM GAA	6.31e-04	5	150	2	PS00707
Domain	ATP-synt_ab_N	ATP6V1B2 ATP5F1B	6.31e-04	5	150	2	PF02874
Domain	ATPase_F1/V1/A1_a/bsu_N	ATP6V1B2 ATP5F1B	6.31e-04	5	150	2	IPR004100
Domain	ATPase_a/bsu_AS	ATP6V1B2 ATP5F1B	6.31e-04	5	150	2	IPR020003
Domain	ATP-synt_ab_C	ATP6V1B2 ATP5F1B	6.31e-04	5	150	2	PF00306
Domain	ATP-synt_ab	ATP6V1B2 ATP5F1B	6.31e-04	5	150	2	PF00006
Domain	ATPASE_ALPHA_BETA	ATP6V1B2 ATP5F1B	6.31e-04	5	150	2	PS00152
Domain	OSR1_C	WNK1 WNK3	9.41e-04	6	150	2	PF12202
Domain	Glyco_hydro_31_AS	MGAM GAA	9.41e-04	6	150	2	IPR030458
Domain	ATPase_F1/V1/A1_a/bsu_nucl-bd	ATP6V1B2 ATP5F1B	9.41e-04	6	150	2	IPR000194
Domain	Kinase_OSR1/WNK_CCT	WNK1 WNK3	9.41e-04	6	150	2	IPR024678
Domain	-	FAT4 LAMA3 FAT1 CNTNAP2 USH2A	1.01e-03	95	150	5	2.60.120.200
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	EPS15 SETX APC MED1 POLA2 WNK1 ECT2 TRIP12 SH3BP4 STK10 USP10 TBC1D4 MYPN NAV2 PLA2G4A RPRD2 MARK2 DDX24 PALLD	1.56e-12	503	156	19	16964243
Pubmed	A human MAP kinase interactome.	SYNPO2 SETX CCDC186 APC RAP1GAP2 LAMA3 WNK1 DCTN1 GAB2 SH3BP4 NAV2 TNK2 BAIAP2 TNS1 SOS1	6.08e-09	486	156	15	20936779
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	ATP6V1B2 ZNF609 MYO1D FXR2 NT5E GART APC CLASP2 MED1 DCTN1 TRIP12 AHDC1 SH3BP4 USP10 TBC1D4 ZNF608 SIPA1L1 AHR DLAT MLLT6 MARK2 DDX24 ATP5F1B	9.55e-09	1247	156	23	27684187
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	EPS15 SYNPO2 ZNF609 SCAMP3 KDM5D WNK1 TRIP12 SH3BP4 STK10 BUB1 ATF7IP2 TNK2 MLLT6 SOS1	1.02e-08	430	156	14	35044719
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TANC2 DIP2B SETX APC CLASP2 WNK1 ECT2 TRIP12 GAB2 SH3BP4 VPS13D TBC1D4 SIPA1L1 NAV2 BAIAP2 MARK2 PAN3 PALLD WNK3	1.26e-08	861	156	19	36931259
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	A2M DIP2B ZNF609 SETX DOCK10 APC PEX1 BTAF1 ECT2 SH3BP4 FARP2 PRKAA1 BUB1 DBR1 MARK2 PALLD	4.37e-08	650	156	16	38777146
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	TANC2 LCA5 ZNF609 PITRM1 CDH23 CLASP2 SCAMP3 MED1 WNK1 ECT2 DCTN1 GAB2 SH3BP4 TBC1D4 SIPA1L1 PTPRQ BUB1 TTI1 BAIAP2 MARK2 PAN3 DDX24	1.23e-07	1321	156	22	27173435
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	COL17A1 CACHD1 TRIP12 VPS13D TBC1D4 SIPA1L1 CNTNAP2 PDZD2	1.40e-07	130	156	8	12421765
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	TANC2 ZNF609 SPAM1 ATXN7L2 FXR2 BCL7B PEX1 HIC2 C2CD5 SETD2 FAT1 ZFHX4 ZNF608 FAM120C SIPA1L1 AHR DLAT DDX24 SENP7 SOS1	1.53e-07	1116	156	20	31753913
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	TBC1D19 DIP2B EPS15 MBTPS1 ZNF609 PCDHGB1 INPP4A LAMA3 CLASP2 BTAF1 AHDC1 SH3BP4 FARP2 STK10 USP10 TBC1D4 ZNF608 FAM120C TNK2 RPRD2 BAIAP2 PAN3 PDZD2	2.34e-07	1489	156	23	28611215
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	CFAP47 FAT4 SETX FXR2 DNAH2 HIC2 ZNF831 ECT2 TRIP12 FRY TBC1D4 FAM120C PKD1 FBXO43 AHR TMEM200C	2.34e-07	736	156	16	29676528
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	DIP2B BTAF1 MED1 POLA2 TRIP12 C2CD5 STK10 USP10 SETD2 TBC1D4 SIPA1L1 PLA2G4A MARK2 DDX24 SOS1	2.35e-06	774	156	15	15302935
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	TANC2 ATP6V1B2 APC NCAM1 C2CD5 FAM163B SIPA1L1 BAIAP2 MARK2 SOS1	4.15e-06	347	156	10	17114649
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	TANC2 APC CLASP2 WNK1 C2CD5 USP10 VIPAS39 TBC1D4 SIPA1L1 BAIAP2 MARK2	6.00e-06	446	156	11	24255178
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TANC2 DIP2B EPS15 FXR2 APC NCAM1 CLASP2 DCTN1 CACNG2 USP10 FRY FAM120C SIPA1L1 BAIAP2 TNS1 WNK3	7.53e-06	963	156	16	28671696
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	MBTPS1 ZNF609 PITRM1 INPP4A HIC2 CLASP2 MED1 HSD11B1L POLA2 WNK1 DCTN1 PREX2 C2CD5 USP10 SETD2 AHR DLAT SEC63 SOS1	8.51e-06	1327	156	19	32694731
Pubmed	Genetic linkage analysis and homology relationships of genes located on human chromosome 11q.	NCAM1 PGR MS4A1	1.04e-05	10	156	3	1679745
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	A2M TANC2 DIP2B INPP4A APC CLASP2 PREX2 USP10 FRY FAM120C SIPA1L1	1.08e-05	475	156	11	31040226
Pubmed	A mouse model for endometrioid ovarian cancer arising from the distal oviduct.	APC PGR	2.00e-05	2	156	2	24474556
Pubmed	Akkermansia muciniphila inhibits tryptophan metabolism via the AhR/β-catenin signaling pathway to counter the progression of colorectal cancer.	APC AHR	2.00e-05	2	156	2	37781044
Pubmed	Histone methyltransferase SETD2 modulates alternative splicing to inhibit intestinal tumorigenesis.	APC SETD2	2.00e-05	2	156	2	28825595
Pubmed	Reciprocal regulation of Rag expression in thymocytes by the zinc-finger proteins, Zfp608 and Zfp609.	ZNF609 ZNF608	2.00e-05	2	156	2	23076336
Pubmed	Genetic variation in genes regulating skeletal muscle regeneration and tissue remodelling associated with weight loss in chronic obstructive pulmonary disease.	EFNA2 BAIAP2	2.00e-05	2	156	2	34523824
Pubmed	Suppression of intestinal polyposis in Apc(delta 716) knockout mice by an additional mutation in the cytosolic phospholipase A(2) gene.	APC PLA2G4A	2.00e-05	2	156	2	10969066
Pubmed	Gene conversion and purifying selection of a placenta-specific ERV-V envelope gene during simian evolution.	ERVV-2 ERVV-1	2.00e-05	2	156	2	18826608
Pubmed	Regulation of Na+-K+-Cl- cotransporter type 2 by the with no lysine kinase-dependent signaling pathway.	WNK1 WNK3	2.00e-05	2	156	2	30917032
Pubmed	MARK2 inhibits the growth of HeLa cells through AMPK and reverses epithelial-mesenchymal transition.	PRKAA1 MARK2	2.00e-05	2	156	2	28560405
Pubmed	Differential evolutionary fate of an ancestral primate endogenous retrovirus envelope gene, the EnvV syncytin, captured for a function in placentation.	ERVV-2 ERVV-1	2.00e-05	2	156	2	23555306
Pubmed	Usherin is required for maintenance of retinal photoreceptors and normal development of cochlear hair cells.	CDH23 USH2A	2.00e-05	2	156	2	17360538
Pubmed	Integrated Analysis of ECT2 and COL17A1 as Potential Biomarkers for Pancreatic Cancer.	COL17A1 ECT2	2.00e-05	2	156	2	35722628
Pubmed	Intestinal tumorigenesis is not affected by progesterone signaling in rodent models.	APC PGR	2.00e-05	2	156	2	21818351
Pubmed	Bystander-activated memory CD8 T cells control early pathogen load in an innate-like, NKG2D-dependent manner.	DCTN1 MREG	2.00e-05	2	156	2	23523350
Pubmed	CD56bright cells increase expression of {alpha}4 integrin at ovulation in fertile cycles.	NCAM1 ITGA4	2.00e-05	2	156	2	18628406
Pubmed	Induction of cardiac angiogenesis requires killer cell lectin-like receptor 1 and α4β7 integrin expression by NK cells.	ITGA4 KLRG1	2.00e-05	2	156	2	20971926
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	EPS15 ZNF609 INPP4A APC DCTN1 TBC1D4 ZFHX4 ZNF608 BUB1 ATF7IP2	2.08e-05	418	156	10	34709266
Pubmed	Identification of 14-3-3epsilon substrates from embryonic murine brain.	TANC2 GAB2 TBC1D4 BAIAP2 MARK2 ATP5F1B	3.04e-05	132	156	6	16944949
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	SETX APC PEX1 CLASP2 ITGA9 WNK1 DCTN1 TRIP12 C2CD5 ESCO2 SIPA1L1 MYPN PRKAA1 PAN3 SEC63 TNS1	3.19e-05	1084	156	16	11544199
Pubmed	Genome wide association study (GWAS) of Chagas cardiomyopathy in Trypanosoma cruzi seropositive subjects.	SLC9A9 ABCB5 RAP1GAP2 NCAM1 MYPN KCNMB3	3.31e-05	134	156	6	24324551
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	FXR2 CDH23 CLASP2 ECT2 TRIP12 FAT1 ZFHX4 DBR1 PALLD	3.96e-05	361	156	9	26167880
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	APC CLASP2 VPS13D TBC1D4 SIPA1L1 MYPN PALLD	4.68e-05	209	156	7	36779422
Pubmed	Modifier genes in mice and humans.	APC MREG PLA2G4A	4.75e-05	16	156	3	11256068
Pubmed	Modifier genes and protective alleles in humans and mice.	APC CDH23 PLA2G4A	4.75e-05	16	156	3	12787792
Pubmed	Molecular characterization of the ankle-link complex in cochlear hair cells and its role in the hair bundle functioning.	CDH23 PTPRQ USH2A	4.75e-05	16	156	3	17567809
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	EPS15 FAT4 SETX CCDC186 APC NCAM1 CLASP2 TRIP12 GAB2 SH3BP4 FAT1 VIPAS39 BAIAP2	5.21e-05	777	156	13	35844135
Pubmed	The Med1 subunit of the mediator complex induces liver cell proliferation and is phosphorylated by AMP kinase.	MED1 PRKAA1	5.98e-05	3	156	2	23943624
Pubmed	USP10 suppresses tumor progression by inhibiting mTOR activation in hepatocellular carcinoma.	USP10 PRKAA1	5.98e-05	3	156	2	30056112
Pubmed	The role of PGE2 in intestinal inflammation and tumorigenesis.	APC PLA2G4A	5.98e-05	3	156	2	25460828
Pubmed	AHR/TET2/NT5E axis downregulation is associated with the risk of systemic lupus erythematosus and its progression.	NT5E AHR	5.98e-05	3	156	2	36314527
Pubmed	AMPK is required for uterine receptivity and normal responses to steroid hormones.	PGR PRKAA1	5.98e-05	3	156	2	32191914
Pubmed	Loss of APC induces polyploidy as a result of a combination of defects in mitosis and apoptosis.	APC BUB1	5.98e-05	3	156	2	17227893
Pubmed	SETD2 Restricts Prostate Cancer Metastasis by Integrating EZH2 and AMPK Signaling Pathways.	SETD2 PRKAA1	5.98e-05	3	156	2	32619406
Pubmed	Rho GTPase Cdc42 is a direct interacting partner of Adenomatous Polyposis Coli protein and can alter its cellular localization.	APC BAIAP2	5.98e-05	3	156	2	21311754
Pubmed	Polycystin-1 is required for stereocilia structure but not for mechanotransduction in inner ear hair cells.	CDH23 PKD1	5.98e-05	3	156	2	21865467
Pubmed	Deletion of cytosolic phospholipase A(2) suppresses Apc(Min)-induced tumorigenesis.	APC PLA2G4A	5.98e-05	3	156	2	11274413
Pubmed	SH3BP4 Regulates Intestinal Stem Cells and Tumorigenesis by Modulating β-Catenin Nuclear Localization.	APC SH3BP4	5.98e-05	3	156	2	30811977
Pubmed	A calcium-dependent phospholipase A2 (cPLA2) expression is regulated by MIG-6 during endometrial tumorigenesis.	PGR PLA2G4A	5.98e-05	3	156	2	30773264
Pubmed	Osteopontin mediates macrophage chemotaxis via α4 and α9 integrins and survival via the α4 integrin.	ITGA4 ITGA9	5.98e-05	3	156	2	23192608
Pubmed	ASC-associated inflammation promotes cecal tumorigenesis in aryl hydrocarbon receptor-deficient mice.	APC AHR	5.98e-05	3	156	2	23455376
Pubmed	PAR-1 and the microtubule-associated proteins CLASP2 and dynactin-p50 have specific localisation on mouse meiotic and first mitotic spindles.	CLASP2 MARK2	5.98e-05	3	156	2	16123238
Pubmed	A functional role for AMPK in female fertility and endometrial regeneration.	PGR PRKAA1	5.98e-05	3	156	2	30328345
Pubmed	Deubiquitination and Activation of AMPK by USP10.	USP10 PRKAA1	5.98e-05	3	156	2	26876938
Pubmed	Regulation of cell migration by α4 and α9 integrins.	ITGA4 ITGA9	5.98e-05	3	156	2	30819933
Pubmed	Autism-associated familial microdeletion of Xp11.22.	FAM120C WNK3	5.98e-05	3	156	2	18498374
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	TANC2 EPS15 RAP1GAP2 CLASP2 POLA2 WNK1 GAB2 FARP2 STK10 SETD2 MYPN AHR RPRD2 DBR1 PAN3	7.22e-05	1038	156	15	26673895
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	DOCK10 HIC2 WNK1 ZNF608 SIPA1L1 NAV2 RPRD2	7.44e-05	225	156	7	12168954
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	TANC2 ATP6V1B2 MYO1D INPP4A APC NCAM1 CLASP2 DCTN1 USP10 C12orf50 FAM120C SIPA1L1 PRKAA1 DLAT BAIAP2 MARK2 TNS1 ATP5F1B	8.02e-05	1431	156	18	37142655
Pubmed	IgSF8: a developmentally and functionally regulated cell adhesion molecule in olfactory sensory neuron axons and synapses.	NCAM1 ITGA4 ITGA9	9.54e-05	20	156	3	22687584
Pubmed	Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease.	SLC9A9 ST8SIA1 PALLD	1.11e-04	21	156	3	20708005
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	ZNF609 MYO1D FXR2 APC MED1 TRIP12 USP10 FAM120C PRKAA1 BAIAP2 DDX24 PALLD	1.11e-04	724	156	12	36232890
Pubmed	The human homologue of Bub3 is required for kinetochore localization of Bub1 and a Mad3/Bub1-related protein kinase.	APC BUB1	1.19e-04	4	156	2	9660858
Pubmed	Protein kinase WNK1 promotes cell surface expression of glucose transporter GLUT1 by regulating a Tre-2/USP6-BUB2-Cdc16 domain family member 4 (TBC1D4)-Rab8A complex.	WNK1 TBC1D4	1.19e-04	4	156	2	20937822
Pubmed	A role for the Adenomatous Polyposis Coli protein in chromosome segregation.	APC BUB1	1.19e-04	4	156	2	11283619
Pubmed	WNK kinases, a novel protein kinase subfamily in multi-cellular organisms.	WNK1 WNK3	1.19e-04	4	156	2	11571656
Pubmed	Human hypertension caused by mutations in WNK kinases.	WNK1 WNK3	1.19e-04	4	156	2	11498583
Pubmed	SLC26A9 is a Cl(-) channel regulated by the WNK kinases.	WNK1 WNK3	1.19e-04	4	156	2	17673510
Pubmed	Axon morphogenesis and maintenance require an evolutionary conserved safeguard function of Wnk kinases antagonizing Sarm and Axed.	WNK1 WNK3	1.19e-04	4	156	2	34384519
Pubmed	The integrin ligand SVEP1 regulates GPCR-mediated vasoconstriction via integrins α9β1 and α4β1.	ITGA4 ITGA9	1.19e-04	4	156	2	35802072
Pubmed	Par1b links lumen polarity with LGN-NuMA positioning for distinct epithelial cell division phenotypes.	BAIAP2 MARK2	1.19e-04	4	156	2	24165937
Pubmed	WNK1 phosphorylation sites in TBC1D1 and TBC1D4 modulate cell surface expression of GLUT1.	WNK1 TBC1D4	1.19e-04	4	156	2	31816312
Pubmed	Interaction of nebulin SH3 domain with titin PEVK and myopalladin: implications for the signaling and assembly role of titin and nebulin.	MYPN SOS1	1.19e-04	4	156	2	12482578
Pubmed	Type XVII collagen (BP180) can function as a cell-matrix adhesion molecule via binding to laminin 332.	COL17A1 LAMA3	1.19e-04	4	156	2	21034821
Pubmed	A neurogenomics approach to gene expression analysis in the developing brain.	CCDC186 NCAM1 WNK1 TRIP12 PKD1 ATP5F1B	1.24e-04	170	156	6	15582152
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	EPS15 ZNF609 FXR2 APC CLASP2 WNK1 FARP2 SETD2 VIPAS39 RPRD2 BAIAP2 SEC63	1.25e-04	733	156	12	34672954
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	EPS15 ATP6V1B2 SETX NT5E APC CLASP2 MED1 ECT2 AHDC1 FARP2 USP10 SETD2 FAM120C SIPA1L1 BAIAP2 MARK2 SEC63 ATP5F1B	1.41e-04	1497	156	18	31527615
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TANC2 RAP1GAP2 CLASP2 BTAF1 WNK1 DCTN1 AHDC1 SH3BP4 STK10 FAT1 EFNA2 PKD1 NAV2 TNK2 MLLT6	1.43e-04	1105	156	15	35748872
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ZNF609 SETX PITRM1 HIC2 CACHD1 USP10 ZNF608 CNTNAP2 NAV2 RPRD2	1.47e-04	529	156	10	14621295
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	EPS15 ATP6V1B2 FXR2 APC FAM120C SIPA1L1 TNK2 BAIAP2 MARK2	1.50e-04	430	156	9	32581705
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	A2M SETX FXR2 BCL7B CLASP2 MED1 TRIP12 ESCO2 USP10 FAM120C AHR DLAT BAIAP2 DBR1 MARK2 SEC63 ATP5F1B	1.52e-04	1371	156	17	36244648
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	BNC2 POLA2 AHDC1 SH3BP4 MREG VPS13D SIPA1L1 TTI1 MARK2 SOS1	1.64e-04	536	156	10	15840001
Pubmed	Stromal Fat4 acts non-autonomously with Dchs1/2 to restrict the nephron progenitor pool.	FAT4 NCAM1 FAT1	1.67e-04	24	156	3	26116661
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	BNC2 POLA2 AHDC1 SH3BP4 MREG VPS13D SIPA1L1 TTI1 MARK2 SOS1	1.69e-04	538	156	10	10512203
Pubmed	Inflammation-dependent overexpression of c-Myc enhances CRL4DCAF4 E3 ligase activity and promotes ubiquitination of ST7 in colitis-associated cancer.	CDH23 HIC2 POLA2 USP10 SETD2 NAV2 DCAF4	1.69e-04	257	156	7	30945288
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	A2M COL17A1 MYO1D FXR2 GART LAMA3 ITGA4 ECT2 TRIP12 USP10 SIPA1L1 BAIAP2 MARK2 SEC63 DDX24 ATP5F1B	1.78e-04	1257	156	16	36526897
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	ATXN7L2 FXR2 APC CLASP2 POLA2 TRIP12 USP10 SIPA1L1 SASS6 MARK2 PAN3 DDX24 TARBP1 DCAF4	1.85e-04	1005	156	14	19615732
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	EPS15 SP2 ZNF609 SETX MED1 AHDC1 USP10 ZNF608 PALLD	1.90e-04	444	156	9	34795231
Pubmed	Evidence that an interaction between EB1 and p150(Glued) is required for the formation and maintenance of a radial microtubule array anchored at the centrosome.	APC DCTN1	1.98e-04	5	156	2	12388762
Pubmed	A genetic interaction network of five genes for human polycystic kidney and liver diseases defines polycystin-1 as the central determinant of cyst formation.	PKD1 SEC63	1.98e-04	5	156	2	21685914
Pubmed	Role of CLASP2 in microtubule stabilization and the regulation of persistent motility.	APC CLASP2	1.98e-04	5	156	2	17113391
Pubmed	Differential biosynthesis of polysialic acid on neural cell adhesion molecule (NCAM) and oligosaccharide acceptors by three distinct alpha 2,8-sialyltransferases, ST8Sia IV (PST), ST8Sia II (STX), and ST8Sia III.	NCAM1 ST8SIA1	1.98e-04	5	156	2	10766765
Pubmed	Structural and biochemical characterization of the KLHL3-WNK kinase interaction important in blood pressure regulation.	WNK1 WNK3	1.98e-04	5	156	2	24641320
Interaction	YWHAH interactions	TANC2 LCA5 DIP2B SETX FXR2 APC CLASP2 MED1 POLA2 WNK1 ECT2 DCTN1 TRIP12 GAB2 SH3BP4 VPS13D TBC1D4 MS4A1 SIPA1L1 PRKAA1 NAV2 BAIAP2 MARK2 PAN3 PALLD WNK3	2.06e-07	1102	152	26	int:YWHAH
Interaction	YWHAZ interactions	TANC2 LCA5 SYNPO2 APC RAP1GAP2 CLASP2 ITGA4 WNK1 ECT2 DCTN1 TRIP12 GAB2 SH3BP4 VPS13D TBC1D4 MS4A1 SIPA1L1 PRKAA1 NAV2 DLAT TNK2 BAIAP2 MARK2 DDX24 TNS1 SENP7 ATP5F1B	1.86e-06	1319	152	27	int:YWHAZ
Interaction	YWHAB interactions	TANC2 LCA5 APC NCAM1 CLASP2 ITGA4 WNK1 ECT2 DCTN1 TRIP12 GAB2 SH3BP4 VPS13D VIPAS39 TBC1D4 MS4A1 SIPA1L1 PRKAA1 NAV2 PRMT9 BAIAP2 MARK2 DDX24	2.22e-06	1014	152	23	int:YWHAB
GeneFamily	Cadherin related	FAT4 CDH23 FAT1	8.50e-05	17	93	3	24
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ECT2 PREX2 FARP2 SOS1	3.71e-04	66	93	4	722
GeneFamily	Zinc fingers C2H2-type\|Sp transcription factors	SP2 SP9	9.20e-04	9	93	2	755
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	MYO1D APC WNK1 PREX2 TNS1	2.43e-03	181	93	5	694
GeneFamily	F-type ATPases\|Mitochondrial complex V: ATP synthase subunits	ATP5MC1 ATP5F1B	3.80e-03	18	93	2	416
GeneFamily	CD molecules\|Integrin alpha subunits	ITGA4 ITGA9	3.80e-03	18	93	2	1160
GeneFamily	Phospholipases\|C2 domain containing phospholipases	PLCZ1 PLA2G4A	4.23e-03	19	93	2	832
GeneFamily	F-type ATPases\|Mitochondrial complex V: ATP synthase subunits	ATP5MC1 ATP5F1B	4.23e-03	19	93	2	644
Coexpression	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_UP	RSPH4A PEX1 MMACHC NAV2 SASS6 TTI1 C2CD6 DBR1	1.96e-05	197	151	8	M4257
Coexpression	GSE22501_PERIPHERAL_BLOOD_VS_CORD_BLOOD_TREG_DN	EVI2B NCAM1 ITGA9 C2CD5 EFNA2 DLAT PLA2G4A KLRG1	2.11e-05	199	151	8	M8367
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	TANC2 DIP2B INPP4A CCDC186 APC RAP1GAP2 PEX1 LAMA3 NCAM1 AHDC1 C2CD5 CACNG2 FRY ZFHX4 CNTNAP2 TNK2 C2CD6 TARBP1 WNK3	2.11e-05	1106	151	19	M39071
Coexpression	GSE43863_TH1_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_DN	LCA5 MBTPS1 NT5E CCDC186 BCL7B ST8SIA1 ZDHHC20 PKD1	2.18e-05	200	151	8	M9765
Coexpression	LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES	A2M SYNPO2 MYO1D FRY PAN3 TNS1 PALLD	3.34e-05	155	151	7	M39246
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	EPS15 ZNF609 SETX INPP4A DOCK10 EVI2B BTAF1 ITGA4 MED1 ZNF831 WNK1 TRIP12 EPG5 STK10 SETD2 TBC1D4 AHR TNK2 MLLT6 DDX24 SENP7 SOS1	4.66e-05	1492	151	22	M40023
Coexpression	FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON	RAP1GAP2 HIC2 PKD1 FAM227A TNK2 TARBP1 PDZD2	5.17e-05	166	151	7	M39026
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TANC2 MYO1D DACT2 LAMA3 ITGA9 NAV2 PLA2G4A BAIAP2	2.63e-07	184	154	8	ab2f06906fc7a9931dfa0864ef506832b07fb93e
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M FAT4 SYNPO2 NCAM1 ST8SIA1 NAV2 PLA2G4A PALLD	3.23e-07	189	154	8	c734e5693808a0333139e87bd5be2597a9252afe
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYO1D LAMA3 PTPRQ ATF7IP2 NAV2 TNS1 PALLD PDZD2	3.36e-07	190	154	8	30b50d183d7649146eb1e79b47ba897355f1998a
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M FAT4 SYNPO2 NCAM1 ST8SIA1 NAV2 PLA2G4A PALLD	3.50e-07	191	154	8	c54c420a94dc749ebc67fc64c5614663f4b9798d
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M FAT4 SYNPO2 NCAM1 ST8SIA1 NAV2 PLA2G4A PALLD	3.50e-07	191	154	8	cb0aee740b08f7d5fdd2717ecf7429043b277ae7
ToppCell	Children_(3_yrs)-Immune-natural_killer_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	BNC2 INPP4A DOCK10 RAP1GAP2 NCAM1 ZNF831 STK10 KLRG1	3.50e-07	191	154	8	6345c1aa0fd2f9f2154a44f9393bf7c72bb1f44e
ToppCell	Children_(3_yrs)-Immune-natural_killer_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	BNC2 INPP4A DOCK10 RAP1GAP2 NCAM1 ITGA4 ZNF831 STK10	3.79e-07	193	154	8	1cb666375bc4e1b11a146d20896c9b5ae6fd0887
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	TANC2 ZNF609 MYO1D SIPA1L1 NAV2 PAN3 PDZD2 SOS1	4.26e-07	196	154	8	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	A2M FAT4 SYNPO2 NCAM1 ST8SIA1 PGR PLA2G4A PALLD	4.26e-07	196	154	8	a12dd986df65c36f248cf10815c3b8b6238613b0
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	A2M FAT4 SYNPO2 NCAM1 ST8SIA1 PGR PLA2G4A PALLD	4.26e-07	196	154	8	3e6803587d8566fd08cb8b290be3b6461743d79c
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	A2M BNC2 SLC9A9 FAT4 SYNPO2 ITGA9 PREX2 NAV2	4.43e-07	197	154	8	0dd71e399f253787fa546a7e90c5373180b89ffd
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	TANC2 ZNF609 MYO1D GAB2 SIPA1L1 NAV2 PAN3 PDZD2	4.60e-07	198	154	8	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_CTL\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	A2M INPP4A DOCK10 RAP1GAP2 ITGA4 ZNF831 STK10 KLRG1	4.78e-07	199	154	8	eb188b0b457136b6ee485d3b3052baa30d9c0002
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	FAT4 DOCK10 PREX2 FAT1 ZFHX4 ZNF608 CNTNAP2 MEGF11	4.96e-07	200	154	8	d0167f96314be78b6d867bbcc6e4396071d931b8
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	A2M BNC2 SLC9A9 FAT4 ST8SIA1 PREX2 PGR NAV2	4.96e-07	200	154	8	3dd022e974fec7013ba18f333da63f58fbf2dd7c
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated\|COVID-19_Mild / Disease, condition lineage and cell class	A2M FAT4 SETX INPP4A NCAM1 MLLT6 KLRG1 PALLD	4.96e-07	200	154	8	2281debd86e5d92e8fe0397aec9ef670800f7471
ToppCell	Control-NK\|World / Disease group and Cell class	A2M TANC2 PCDHGA5 NCAM1 CACHD1 SH3BP4 NAV2	6.80e-07	143	154	7	fe08adc9472dfd4242497d6c614d0490713261da
ToppCell	343B-Epithelial_cells-Epithelial-E_(AT2)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	MYO1D LAMA3 MMACHC SETD2 MALRD1 C12orf50 KCNMB3	7.46e-07	145	154	7	80684ec249fa445c1b35f94608a4a6824d53f2d9
ToppCell	343B-Epithelial_cells-Epithelial-E_(AT2)\|343B / Donor, Lineage, Cell class and subclass (all cells)	MYO1D LAMA3 MMACHC SETD2 MALRD1 C12orf50 KCNMB3	7.46e-07	145	154	7	cb534333fba44b241b14fb0d7b74e843f4e7f9f8
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ABCB5 DNAH2 DOCK10 CDH23 FAT1 SP9 TMEM200C	3.16e-06	180	154	7	392bc71a69653ba12de31bed4e9357f181094641
ToppCell	Children_(3_yrs)-Mesenchymal-myofibroblast_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	A2M BNC2 FAT4 SYNPO2 ITGA9 PGR PALLD	3.16e-06	180	154	7	01f2e5d96016823482f89ba503d007d4bd88eeac
ToppCell	COVID-19-kidney-NK\|COVID-19 / Disease (COVID-19 only), tissue and cell type	INPP4A DOCK10 RAP1GAP2 NCAM1 ITGA4 ZNF831 STK10	3.28e-06	181	154	7	8906ee8a7a1616dfe8c3b5c73988416641213629
ToppCell	Severe-Myeloid-mDC\|Severe / Condition, Lineage, Cell class and cell subclass	A2M ITGA4 PREX2 PGR MREG TBC1D4 PALLD	3.28e-06	181	154	7	00f2949b609ac21bd2da6fd8f685739eeb2f48ad
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ABCB5 DNAH2 DOCK10 CDH23 FAT1 SP9 TMEM200C	3.28e-06	181	154	7	8fd64404e57c22c204d835fc5626f73554257b19
ToppCell	Severe-Myeloid-mDC-\|Severe / Condition, Lineage, Cell class and cell subclass	A2M ITGA4 PREX2 PGR MREG TBC1D4 PALLD	3.28e-06	181	154	7	51ded98c76ec35ab1d24ac3ab98280381daa9831
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NCAM1 FRY PKD1 AHR SASS6 PRMT9 DCAF4	3.52e-06	183	154	7	3ef9ac1ae13b6172f9121ab1c129ecaa0fef460f
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M MGAM FAT4 FAT1 ZFHX4 PTPRQ USH2A	3.65e-06	184	154	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYO1D LAMA3 PTPRQ ATF7IP2 NAV2 TNS1 PDZD2	3.65e-06	184	154	7	57c792e6e2fedba25d3350ffe649fd74750b579d
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M MGAM FAT4 FAT1 ZFHX4 PTPRQ USH2A	3.65e-06	184	154	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M MGAM FAT4 FAT1 ZFHX4 PTPRQ USH2A	3.65e-06	184	154	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	SYNPO2 NCAM1 FRY TBC1D4 MYPN PALLD PDZD2	3.65e-06	184	154	7	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYO1D LAMA3 PTPRQ ATF7IP2 NAV2 TNS1 PDZD2	3.65e-06	184	154	7	d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCell	Control-T_cells-CD8+_T_cells\|Control / group, cell type (main and fine annotations)	A2M DOCK10 ST8SIA1 ITGA4 ZNF831 STK10 KLRG1	3.78e-06	185	154	7	02ab64c0166c0646d1d4c6ed110ef0b75a1096d0
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M SLC9A9 SYNPO2 PGR STK10 ZFHX4 DCAF4	3.78e-06	185	154	7	e1fbec55b71f604189eb2431768fadbaa0453a83
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M SLC9A9 SYNPO2 PGR STK10 ZFHX4 DCAF4	3.78e-06	185	154	7	9d933cd5ebc8368fd37aa83113d2dfa6938ff72d
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	SYNPO2 NCAM1 FRY TBC1D4 MYPN PALLD PDZD2	3.78e-06	185	154	7	6baccb26f999145e51b91d94315bf8d4655bef31
ToppCell	Control-T_cells-NK_cells\|Control / group, cell type (main and fine annotations)	INPP4A DOCK10 RAP1GAP2 NCAM1 ITGA4 ZNF831 STK10	3.78e-06	185	154	7	755c0998c729f462399f1d5e88adf4bfae31be30
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TANC2 DACT2 LAMA3 ITGA9 NAV2 PLA2G4A BAIAP2	3.92e-06	186	154	7	e83718fabb057100835d3357df407f283d23fe16
ToppCell	Cerebellum-Neuronal\|Cerebellum / BrainAtlas - Mouse McCarroll V32	ATP6V1B2 RAP1GAP2 PGR CACNG2 MREG CNTNAP2 DDX24	4.06e-06	187	154	7	61b9d6eb131a674598aa8409d7fa909c8765442d
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	A2M SYNPO2 MYO1D DOCK10 LAMA3 CLASP2 FRY	4.21e-06	188	154	7	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	COVID-19-Heart\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SYNPO2 NCAM1 ITGA9 FRY MYPN PALLD PDZD2	4.51e-06	190	154	7	918ad5037881212008f9f69d5df5da91fd01422c
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M FAT4 SYNPO2 NCAM1 ST8SIA1 PLA2G4A PALLD	4.51e-06	190	154	7	2e592323085ba9c019d678ac2a784462ab470ed9
ToppCell	COVID-19-kidney-NK\|kidney / Disease (COVID-19 only), tissue and cell type	INPP4A DOCK10 EVI2B NCAM1 ITGA4 ZNF831 STK10	4.51e-06	190	154	7	e3ca3c9fb9e27670a5dd128dd6564ff98a57159e
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M FAT4 SYNPO2 NCAM1 ST8SIA1 PLA2G4A PALLD	4.51e-06	190	154	7	445952b70abffadb6ccc1ed4bbf61a88b06b73b3
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M SYNPO2 NCAM1 ST8SIA1 PGR PLA2G4A PALLD	4.67e-06	191	154	7	a58c75e9580139fb370b498d95660f10f3a2a27b
ToppCell	human_hepatoblastoma-Inflammatory_Monocytes\|World / Sample and Cell Type and Tumor Cluster (all cells)	TANC2 BNC2 SLC9A9 DOCK10 ITGA4 GAB2 STK10	4.67e-06	191	154	7	3b59bfc6c106ae8a3fbcd4a74bd128c485724921
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M SYNPO2 NCAM1 ST8SIA1 NAV2 PLA2G4A PALLD	4.67e-06	191	154	7	806b94f567ea09a9f443cd4091e70cdb1253ac08
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	A2M SYNPO2 ITGA9 PGR NAV2 PLA2G4A PALLD	4.67e-06	191	154	7	39092a0aff8097617820c59f5fea9ee2bb4f63a2
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LAMA3 CACHD1 MREG ZNF608 PTPRQ NAV2 PDZD2	4.67e-06	191	154	7	ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	A2M SYNPO2 ITGA9 PGR NAV2 PLA2G4A PALLD	4.67e-06	191	154	7	ee5f1b1c59029c46cbb1a00935c03b9317bb9da9
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FAT4 ABCB5 DOCK10 LAMA3 PREX2 ZNF608 TMEM200C	4.83e-06	192	154	7	3abee376c37c3646da33ac381aa63d50a01607a6
ToppCell	Control-Epithelial-Club\|Control / Disease state, Lineage and Cell class	MYO1D CACHD1 ITGA9 FAT1 ZNF608 AHR NAV2	4.83e-06	192	154	7	d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	A2M BNC2 FAT4 SYNPO2 NCAM1 ITGA9 FAT1	4.83e-06	192	154	7	72881b280a415e65f87a80ca1369cbb0b722a0c4
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3\|lymph-node_spleen / Manually curated celltypes from each tissue	ABCB5 MYRFL SH3BP4 FRY AHR NAV2 PDZD2	4.83e-06	192	154	7	e16035b3328f9b1b2e28d234c62ba88387540550
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DOCK10 MYRFL PREX2 FAT1 ZNF608 CNTNAP2 SP9	4.83e-06	192	154	7	67d6230e32d446dcb12047fae2c3f1faa80dd720
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_10\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SYNPO2 ST8SIA1 ITGA4 MREG TBC1D4 ZNF608 PALLD	5.00e-06	193	154	7	7426a30ed01e5c8376b3e0ebe0f1057cfee88340
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_10\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	SYNPO2 ST8SIA1 ITGA4 MREG TBC1D4 ZNF608 PALLD	5.00e-06	193	154	7	a2194012dfa0174c6160900625c44e0fd04c50e7
ToppCell	nucseq-Immune-Immune_Myeloid-pMON-pMON\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SLC9A9 INPP4A RAP1GAP2 CDH23 ITGA4 STK10 SIPA1L1	5.17e-06	194	154	7	e237384b02be460d44eeada3026a5691c66f6fc1
ToppCell	nucseq-Immune-Immune_Myeloid-pMON\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SLC9A9 INPP4A RAP1GAP2 CDH23 ITGA4 STK10 SIPA1L1	5.17e-06	194	154	7	0bc83ae79873a5e473e6e1e3111924cd003986a1
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	NCAM1 FRY TBC1D4 ZNF608 MYPN PALLD PDZD2	5.17e-06	194	154	7	c3535f7cc0076653c72db582047cff053c322397
ToppCell	COVID-19-lung-NK/NKT\|lung / Disease (COVID-19 only), tissue and cell type	BNC2 DOCK10 RAP1GAP2 NCAM1 ITGA4 ZNF831 STK10	5.35e-06	195	154	7	3ab941a369e3815f338890b116dc77aefa054098
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M SYNPO2 NCAM1 ST8SIA1 PGR PLA2G4A PALLD	5.53e-06	196	154	7	ba869f7a86f37fd6d84d6ad69baca0e0faaf5887
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M SYNPO2 NCAM1 ST8SIA1 PGR PLA2G4A PALLD	5.53e-06	196	154	7	30ad56d49000e4ddce73b4443b3994564bd1e2d6
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	A2M SYNPO2 COL17A1 LAMA3 FAT1 NAV2 TNS1	5.72e-06	197	154	7	f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	TANC2 DACT2 LAMA3 FAT1 NAV2 PLA2G4A BAIAP2	5.91e-06	198	154	7	285f729140b1df029c24f6ca1d2438470ac51794
ToppCell	COVID-19-Myeloid-Migratory_DC\|Myeloid / Condition, Lineage and Cell class	SYNPO2 ST8SIA1 ITGA4 MREG TBC1D4 ZNF608 PALLD	5.91e-06	198	154	7	90f3b227cbc61c268d6d94bc9945a08d83d2d3d5
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Mast_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BNC2 DOCK10 RAP1GAP2 ST8SIA1 ITGA9 PLA2G4A WNK3	6.31e-06	200	154	7	9156f8fd61a833891d2f7b7fadd693b81b1e2d5a
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BNC2 DOCK10 RAP1GAP2 ST8SIA1 ITGA9 PLA2G4A WNK3	6.31e-06	200	154	7	566fe2e78e6f35399ec6aad5964f6d4d8ade82c6
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR\|Neuronal / cells hierarchy compared to all cells using T-Statistic	DOCK10 LAMA3 PREX2 FAT1 ZFHX4 ZNF608 MEGF11	6.31e-06	200	154	7	862db57d043bdf3cb059fbfc8b29bc1eafdf64ec
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR--L1\|Neuronal / cells hierarchy compared to all cells using T-Statistic	DOCK10 LAMA3 PREX2 FAT1 ZFHX4 ZNF608 MEGF11	6.31e-06	200	154	7	a91345f268f13170c27309333603eb82400c9947
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	DOCK10 LAMA3 PREX2 FAT1 ZFHX4 ZNF608 MEGF11	6.31e-06	200	154	7	d416a7be1a4e6232fb58a9687774da24821f1fdd
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T\|COVID-19_Severe / Disease, condition lineage and cell class	A2M INPP4A NCAM1 ZNF831 STK10 MLLT6 KLRG1	6.31e-06	200	154	7	f72bc3f6606ae77fe1b0a972e35b3ce0727804d9
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ASIC5 MYPN PTPRQ BUB1 C2CD6 USH2A	1.15e-05	145	154	6	96712c68ab759d7ade0d912581a1a7c25dc6def8
ToppCell	droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TANC2 DOCK10 ECT2 GAB2 STK10 SIPA1L1	2.22e-05	163	154	6	8dc0128eeede933537e3bcc5d6ec0322711552f3
ToppCell	droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TANC2 DOCK10 ECT2 GAB2 STK10 SIPA1L1	2.22e-05	163	154	6	fd243ca223079033be480a24817a399f281fa4d4
ToppCell	facs-Aorta-Heart-3m-Mesenchymal-fibrocyte\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF9 DOCK10 ITGA4 MREG TBC1D4 MS4A1	2.38e-05	165	154	6	8a52f2dbcbd2bc1662b5e3fac381463fdcc3bf14
ToppCell	facs-Kidney-nan-3m-Lymphocytic-B_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DIP2B MYRFL ZNF831 ZNF608 MS4A1 PAN3	2.46e-05	166	154	6	6a948aefd283a2572da37b59dbc142b6e686b024
ToppCell	facs-Kidney-nan-3m-Lymphocytic-B_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DIP2B MYRFL ZNF831 ZNF608 MS4A1 PAN3	2.46e-05	166	154	6	8d0c4eb90a2c006f96ae61d3d94c96fb64bc0c4d
ToppCell	Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	DACT2 RAP1GAP2 ST8SIA1 PGR CACNG2 SKOR1	2.55e-05	167	154	6	9efb9511a211d0824bb97f82c1a5860c43d2138f
ToppCell	Cerebellum-Neuronal-Inhibitory\|Cerebellum / BrainAtlas - Mouse McCarroll V32	DACT2 RAP1GAP2 ST8SIA1 PGR CACNG2 SKOR1	2.55e-05	167	154	6	904c613aac3f9919a432b110bb1dcc832b5aec0a
ToppCell	5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TANC2 NCAM1 FARP2 FRY ZNF608 PLA2G4A	2.64e-05	168	154	6	8072d0496b7b730c4601009eaa69ec5366d26d73
ToppCell	10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	ST8SIA1 ITGA4 FRY SIGLEC10 UGT2B11 C13orf42	3.01e-05	172	154	6	3a76cfb2832790144a6da6406469ead0767916b5
ToppCell	Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	A2M BNC2 FAT4 SYNPO2 ITGA9 PGR	3.11e-05	173	154	6	1f16d47f5548e257e4b17f8070c5619780a9c5fd
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SPAM1 ITGA4 ESCO2 BUB1 SIGLEC10 FBXO43	3.21e-05	174	154	6	7b318796728001c17b4043d2b033330c7be40c78
ToppCell	Mesenchymal_cells-Osteo-CAR\|Mesenchymal_cells / Lineage and Cell class	A2M FAT4 NCAM1 FAT1 NAV2 PALLD	3.21e-05	174	154	6	430e3cd61bc2a471959faa40e817aa4dd7d82d28
ToppCell	Control-Epithelial_cells-AT1\|Control / group, cell type (main and fine annotations)	LAMA3 PTPRQ ATF7IP2 NAV2 TNS1 PDZD2	3.21e-05	174	154	6	548d7f2b958a2bfd2c95eb049ceaab55a559c77d
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAT4 SYNPO2 PGR NAV2 TNS1 PALLD	3.31e-05	175	154	6	1799a7be623dc3bf53ba580a7c47d2619969d708
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ATXN7L2 CACHD1 MYRFL ITGA9 ESCO2 PTPRQ	3.53e-05	177	154	6	75cb2067a3f2d1b5a964890b02b604d1e79bd163
ToppCell	Control-Epithelial_alveolar-AT_1-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LAMA3 ITGA9 PTPRQ NAV2 BAIAP2 WNK3	3.53e-05	177	154	6	9af14a056eb6d88c6f11b09f6d4c0d3448d647d5
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ABCB5 DOCK10 CDH23 OPN1SW SP9 TMEM200C	3.65e-05	178	154	6	08b4a497aca0aeabf4f6a8a55c05b56417b69e78
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M SYNPO2 ZFHX4 NAV2 PLA2G4A PALLD	3.65e-05	178	154	6	d4ecb84e9b1f4ec49c519321156aa10f9bd34cce
ToppCell	10x3'2.3-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	ZNF609 ITGA4 FRY SIGLEC10 UGT2B11 KLRG1	3.76e-05	179	154	6	810972561d1ae5a68389b54ceeac7a49890513a4
ToppCell	LV\|World / Chamber and Cluster_Paper	SYNPO2 NCAM1 ITGA9 TBC1D4 C2CD6 PDZD2	3.88e-05	180	154	6	5ac6f485a58bb29462fec02dfbe8eb70864eafe3
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	BNC2 SYNPO2 NCAM1 ITGA9 FAT1 TMEM200C	4.00e-05	181	154	6	25915e2500430a902db37d79a749ce2990b69810
ToppCell	wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_2\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	SYNPO2 NCAM1 ITGA4 TBX18 ZFHX4 PLA2G4A	4.00e-05	181	154	6	9b2d207dc9fc2228a1555ed360286bb7c2d988ff
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO1D LAMA3 ITGA9 PTPRQ NAV2 BAIAP2	4.00e-05	181	154	6	b45b11428d13950369347e051d4d517efb2bd4fd
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BNC2 LAMA3 FRY FAT1 ZNF608 PALLD	4.00e-05	181	154	6	5f2d3a08577c440c944778d07aa993c6e7873f3d
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	A2M BNC2 ST8SIA1 PREX2 C2CD6 PALLD	4.00e-05	181	154	6	9ede19228ba5c0668a9c06c915510b95585216ef
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BNC2 LAMA3 FRY FAT1 ZNF608 PALLD	4.00e-05	181	154	6	c7c5f7d4c397b4613c772413a0a679377efffff3
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH2 LAMA3 ZFHX4 PTPRQ BAIAP2	4.03e-05	110	154	5	c80d1c3df75648e2c8f6832279c2acca63d76681
Drug	AC1N5XY5	NT5E APC ECT2 FARP2 SETD2	4.61e-07	24	151	5	CID004251231
Disease	autism spectrum disorder (is_implicated_in)	ITGA4 CNTNAP2 BAIAP2	7.01e-05	16	151	3	DOID:0060041 (is_implicated_in)
Disease	Adenocarcinoma of lung (disorder)	GART APC WNK1 MS4A1 AHR TNK2 SOS1	9.64e-05	206	151	7	C0152013
Disease	Amyotrophic Lateral Sclerosis	SETX DCTN1 PLA2G4A DBR1	2.26e-04	58	151	4	C0002736
Disease	Adult junctional epidermolysis bullosa (disorder)	COL17A1 LAMA3	2.58e-04	5	151	2	C0268374
Disease	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT (disorder)	COL17A1 LAMA3	2.58e-04	5	151	2	C2608084
Disease	Polycystic Kidney - body part	PKD1 SEC63	2.58e-04	5	151	2	C1567435
Disease	junctional epidermolysis bullosa non-Herlitz type (implicated_via_orthology)	COL17A1 LAMA3	2.58e-04	5	151	2	DOID:0060738 (implicated_via_orthology)
Disease	pancreatic cancer (is_implicated_in)	APC NCAM1 ITGA4 ITGA9 PALLD	2.84e-04	112	151	5	DOID:1793 (is_implicated_in)
Disease	retinitis pigmentosa (implicated_via_orthology)	DACT2 EPG5 USH2A	3.51e-04	27	151	3	DOID:10584 (implicated_via_orthology)
Disease	pseudohypoaldosteronism (implicated_via_orthology)	WNK1 WNK3	3.85e-04	6	151	2	DOID:4479 (implicated_via_orthology)
Disease	Junctional Epidermolysis Bullosa	COL17A1 LAMA3	3.85e-04	6	151	2	C0079301
Disease	Polycystic Kidney Diseases	PKD1 SEC63	3.85e-04	6	151	2	C0022680
Disease	Autistic Disorder	SLC9A9 MYO1D APC ITGA4 FARP2 CNTNAP2 PLA2G4A	4.09e-04	261	151	7	C0004352
Disease	junctional epidermolysis bullosa (is_implicated_in)	COL17A1 LAMA3	5.37e-04	7	151	2	DOID:3209 (is_implicated_in)
Disease	polycystic liver disease (implicated_via_orthology)	PKD1 SEC63	5.37e-04	7	151	2	DOID:0050770 (implicated_via_orthology)
Disease	autism spectrum disorder (implicated_via_orthology)	SLC9A9 FXR2 SCAMP3 KDM5D CNTNAP2	1.14e-03	152	151	5	DOID:0060041 (implicated_via_orthology)
Disease	response to methotrexate, serum alanine aminotransferase measurement	RAP1GAP2 CACHD1 PDZD2	1.40e-03	43	151	3	EFO_0004735, GO_0031427
Disease	S-warfarin to R-warfarin ratio measurement	SLC9A9 DACT2 RAP1GAP2 STPG1	1.46e-03	95	151	4	EFO_0803331
Disease	Amelogenesis Imperfecta	COL17A1 PEX1	1.66e-03	12	151	2	C0002452
Disease	ovarian serous carcinoma	BNC2 GALK2 LAMA3	1.70e-03	46	151	3	EFO_1001516
Disease	Malignant neoplasm of pancreas	APC BUB1 AHR PALLD	1.90e-03	102	151	4	C0346647
Disease	Weight Gain	VPS13D SIPA1L1 AHR PALLD	1.90e-03	102	151	4	C0043094
Disease	DEAFNESS, AUTOSOMAL RECESSIVE (disorder)	CDH23 PTPRQ	1.96e-03	13	151	2	C1846647
Disease	attempted suicide	NCAM1 ESCO2 TBX18 ATF7IP2 KCNMB3	2.27e-03	178	151	5	EFO_0004321
Disease	caffeine measurement	AHR MEGF11	2.61e-03	15	151	2	EFO_0021177
Disease	factor VII activating protease measurement	ZNF609 USP10 MALRD1	2.84e-03	55	151	3	EFO_0009368
Disease	Amyotrophic lateral sclerosis	SETX DCTN1	3.36e-03	17	151	2	cv:C0002736
Disease	respiratory symptom change measurement, response to placebo	ATF7IP2 NAV2	3.36e-03	17	151	2	EFO_0008344, EFO_0010068
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	DIP2B SETD2	3.36e-03	17	151	2	DOID:0060307 (is_implicated_in)
Disease	colorectal cancer (is_implicated_in)	APC SETD2 FAT1 BUB1	3.52e-03	121	151	4	DOID:9256 (is_implicated_in)
Disease	disease free survival	CCDC168 CNTNAP2	3.77e-03	18	151	2	EFO_0000409
Disease	disease progression measurement	CDH23 ATF7IP2 UGT2B11	3.81e-03	61	151	3	EFO_0008336
Disease	PR interval	EPS15 ABCB5 RAP1GAP2 ITGA9 FAT1 SIPA1L1 NAV2 KCNMB3	4.09e-03	495	151	8	EFO_0004462
Disease	cerebral infarction (is_marker_for)	A2M SOS1	4.20e-03	19	151	2	DOID:3526 (is_marker_for)
Disease	Cardiomyopathies	EPG5 MYPN GAA SOS1	4.55e-03	130	151	4	C0878544
Disease	alpha-tocopherol measurement	USH2A SOS1	4.65e-03	20	151	2	EFO_0007898
Disease	age at menopause	MGAM DOCK10 GAB2 PGR ZFHX4 DCAF4	4.73e-03	302	151	6	EFO_0004704
Disease	bitter alcoholic beverage consumption measurement	MGAM DNAH2 CNTNAP2 SENP7	4.93e-03	133	151	4	EFO_0010092

Protein segments in the cluster

Peptide	Gene	Start	Entry
QDSLSKSPFIPSDYQ	AHR	586	P35869
NSSPEYPRKEFASSS	COL17A1	116	Q9UMD9
KFYHPQSSSANSPSE	FAM227A	341	F5H4B4
LSESAPQSNFSYTQP	EPG5	151	Q9HCE0
YPASKADIPSVAFSS	DCAF4	456	Q8WV16
VSSLQSSPDFSAFPK	MLLT6	346	P55198
TFPESANEKTYSESP	CCDC186	126	Q7Z3E2
TNVKFQSPAYSSVDT	PRMT9	331	Q6P2P2
LSGLSKPVSSYPNTF	BUB1	751	O43683
FKASEQIYGTPSSSP	DCTN1	871	Q14203
SSESEVSPTPYKNDQ	BNC2	366	Q6ZN30
FYSHSTPKEAASSSP	CASTOR1	206	Q8WTX7
VEFKNVSFNYPSRPS	ABCB5	386	Q2M3G0
HSPAPFSKSSTFYRN	FAT4	4701	Q6V0I7
SFSSPYEHLSQPETK	CACHD1	661	Q5VU97
SSPQRKTAAESPFYE	C13orf42	11	A0A1B0GVH6
LTPPFNQSSKTSFYF	ERVV-2	101	B6SEH9
SPQPSYAADANDSKA	AHDC1	596	Q5TGY3
PTSFSTPYSAAKFAL	HSD11B1L	171	Q7Z5J1
NPSEKNSPSTQYCYS	MS4A1	171	P11836
YQLKVDSSTNSSPSP	BCL7B	101	Q9BQE9
SIQPPNKFYSLNSTT	CDH23	816	Q9H251
RPQFSKPQFSTSVYE	CDH23	2506	Q9H251
SSKQPSYSNFPLQVA	ATP5MC1	36	P05496
APSSTFSVRAKQTYP	ATXN7L2	326	Q5T6C5
YAAQTSPSPKAGAAT	ATP5F1B	46	P06576
PTTQSFASDPKYATP	TNK2	816	Q07912
SFPLSSEPFQGSYKV	A2M	191	P01023
NTPESSINYGDTPKS	ECT2	421	Q9H8V3
NDNAPLFTPSEYSVS	PCDHGA5	236	Q9Y5G8
AARPDYIASKASPTS	INPP4A	476	Q96PE3
DPLKAATTPTATYNS	CACNG2	276	Q9Y698
ANSNPPEFTQTAYKA	FAT1	456	Q14517
SLNSSENPYATIKDP	MEGF11	936	A6BM72
FQLDSKPLYTPSSSF	LAMA3	3131	Q16787
NSYKPQASLSPSYID	MBTPS1	476	Q14703
SISSVLKDPDSNPYS	FXR2	506	P51116
VDPAISNNSSSSKPY	MGAM	451	O43451
SNNSSSSKPYGPYDR	MGAM	456	O43451
LKSSVYANAFPSTPV	MGAM	1021	O43451
NFDDAFLTYTTKPPS	KIAA1109	226	Q2LD37
PLRQSVQPSKFSSYS	KDM5D	196	Q9BY66
SEVAFSPKEYNSPSF	C2CD6	501	Q53TS8
LTPPFNQSSKTSFYF	ERVV-1	101	B6SEH8
FKNYTLDSSAAPTPQ	DLAT	176	P10515
PNQYFSLSTKESPDG	PCDHGB1	171	Q9Y5G3
AAAPPDYSKTRSASE	PDZD2	1296	O15018
TQPPKSFVYTFTQQS	EVI2B	136	P34910
AAYELKSYTESPTNP	FAM214A	1056	Q32MH5
KSYTESPTNPQFSPR	FAM214A	1061	Q32MH5
LANTNPLYPDFSTSA	GALK2	81	Q01415
TPAPSAAQTSAPSKY	DIP2B	71	Q9P265
YSASDSCSPPQVKGA	MYRFL	56	Q96LU7
YVPSFAKTSERSNPF	LCA5	556	Q86VQ0
FAVYLQPTSPSSSQK	OR1I1	256	O60431
ESSPSAYTQEAPQEK	MEIOSIN	401	C9JSJ3
SEEQKAYFSTPPAQR	MMACHC	216	Q9Y4U1
PDSAPENITYKNISS	PTPRQ	801	Q9UMZ3
SDPPKDVYYANLSSS	PTPRQ	991	Q9UMZ3
ESSSPDSGYLSPKNQ	PALLD	196	Q8WX93
ASQSPQYSFESLPQK	PGR	551	P06401
SSPSLLNDSAKPYSA	PAN3	191	Q58A45
ADSPPIVNSKYSTFR	FBXO43	51	Q4G163
DSKYSPSVKSPGAVF	ITGA9	71	Q13797
TYGSVPLSSNSPFKV	MALRD1	1851	Q5VYJ5
PEKTESSVYSFSNPL	MALRD1	2126	Q5VYJ5
DYGPQQKSSSSRPSC	KLRG1	21	Q96E93
SPSSKAQQTPSAQDY	DACT2	441	Q5SW24
TSLPPNYLSFQDSAS	DOCK10	811	Q96BY6
YTPTSASFVNKQPTL	BTAF1	176	O14981
ALYPTASTSFSQKSP	FAM163B	71	P0C2L3
SSASQFPNYLPSKAS	FAM120C	501	Q9NX05
EYPATISYSSFPSQK	ASIC5	381	Q9NY37
YCSSFKLFQASPSVP	BRF2	176	Q9HAW0
SSVNYEPSNPSEKGS	ATF7IP2	421	Q5U623
PSYPSYKLENLSSSE	GAA	131	P10253
PKSTVYPIFSASSVN	ESCO2	321	Q56NI9
QAAGPAIPTSNSYSK	MARK2	411	Q7KZI7
KAESPPRFYFSSNGT	ITGA4	526	P13612
YQLVSPAKNPSSLFS	DDX24	56	Q9GZR7
TLYEAPEPIFTSNNS	EFNA2	176	O43921
AISKVQPSSYAPQAT	IL22RA1	381	Q8N6P7
KNGTPFSCFYSPASQ	KCNMB3	181	Q9NPA1
FSVTAACYDPSKPQT	DBR1	341	Q9UK59
YHLPSSSDTLFNSPK	CNTNAP2	1136	Q9UHC6
EEPQIFYNASPSTLS	SPAM1	476	P38567
KEADPSNFANFSAYP	EPS15	836	P42566
CDNPPFYRFTASSKA	FRY	1511	Q5TBA9
KDLPATSPETFNYCT	CCDC168	1326	Q8NDH2
TPASPSSANAFYSLS	FARP2	396	O94887
TTKLSNPHYSPETSA	DNAH2	3486	Q9P225
IPKSFNYSPNSSTSE	RPRD2	586	Q5VT52
SSKPTALPSASSAYF	SASS6	636	Q6UVJ0
SPTEPKNYGSYSTQA	SCAMP3	76	O14828
FYSSTSPPQKFSRQN	CFAP47	1571	Q6ZTR5
KSQPPSIYNASATSV	PEX1	291	O43933
SGPSTPLKNQTYSFS	C2CD5	281	Q86YS7
SKSPAYTPQNLDSES	MED1	1451	Q15648
ASPYSPAKSFSASDE	PKD1	3456	P98161
SYPLSPLSDFATQDS	PLA2G4A	501	P47712
TIPSFFSKSACIYNP	OPN1SW	286	P03999
SVDYLALDFQPSSPS	GAB2	611	Q9UQC2
PAEPNFSTLLTAASY	HIC2	111	Q96JB3
GKTAASPQYSEPESS	RSPH4A	26	Q5TD94
SPNSKQELQPYSGSS	SKOR1	56	P84550
APKAHSYSPDSFNVS	USH2A	2246	O75445
PQSTLSEFYPRDSAK	ATP6V1B2	496	P21281
SQPSNTDAAKPTYTF	SENP7	701	Q9BQF6
KQEVFVYSPSPSSES	RAP1GAP2	671	Q684P5
TYSISIYSPKENPNA	SLC9A9	251	Q8IVB4
LSPFATTTKYPTFQD	SH3BP4	636	Q9P0V3
QSDDPSSSNKGYTPL	TMEM200C	526	A6NKL6
IYPKATRADSSNFNP	PLCZ1	406	Q86YW0
EKEPLVSDNNPYSSF	MREG	26	Q8N565
SFNNYDKSKPVTSPP	NAV2	311	Q8IVL1
SDYTLYPFSTQNPKD	PITRM1	141	Q5JRX3
NDVLFSSTYPSLPKS	SIPA1L1	1611	O43166
FGESKYFPSSSPVNI	SETX	1676	Q7Z333
TIDNSTYSLFPQATP	ST8SIA1	116	Q92185
FSPPSSISNIAFYNK	TANC2	1891	Q9HCD6
FSPSATPSQKYNSRS	POLA2	151	Q14181
QPTSKAYSPRYSISD	SOS1	1186	Q07889
KPVLPSYSDSSAAVA	SP9	261	P0CG40
YTSKETPFLSNPGTN	NT5E	176	P21589
NEAKDFYLATSPPDS	PRKAA1	346	Q13131
PPQSQSKLSDSYSNT	BAIAP2	326	Q9UQB8
VTPFNYNPSPRKSSA	APC	2781	P25054
YNPSPRKSSADSTSA	APC	2786	P25054
PNLSPDKYTSTSYND	C12orf50	371	Q8NA57
PYNYSDSISPFNKSA	CLASP2	1021	O75122
PSSNYSNIKIYNTPS	NCAM1	456	P13591
KSDQSASAPMSFYPQ	ZFHX4	176	Q86UP3
SPASPSKEFYLSNSE	ZDHHC20	76	Q5W0Z9
SPKQESASSSYFVAP	SYNPO2	1056	Q9UMS6
SASSSYFVAPRPKFS	SYNPO2	1061	Q9UMS6
PCSSEKNTDSQAPFY	SPEM3	546	A0A1B0GUW6
GYNFSTSPKLAASPE	TBX18	531	O95935
TAAYPTQSSIPFKSQ	STPG1	26	Q5TH74
TAAVSPSDYLQPAAS	SP2	11	Q02086
PSDYLQPAASTTQDS	SP2	16	Q02086
STPSKAAKFFPYSSA	STK10	951	O94804
DSEPKSFSAPATQAY	TNS1	1041	Q9HBL0
EADKIYSFTDNAPSP	ZNF609	791	O15014
FDPQYNKDATSRPTD	SEC63	256	Q9UGP8
FYLDKSNSPPNSTSK	PREX2	1451	Q70Z35
SNSPPNSTSKAAYVD	PREX2	1456	Q70Z35
RNSFSSYAQLPKPTS	VIPAS39	91	Q9H9C1
ADPNYASEKPSTAFC	SLAMF9	221	Q96A28
PNDASTLKFEVYPTS	UGT2B11	66	O75310
VAKSSLQYSSPAPDG	GART	631	P22102
PSFTAPSFLKSFYQN	TBC1D4	706	O60343
KPSTTYQQPDSSYGA	SETD2	1266	Q9BYW2
EPSTSVSAYDQLKAP	ZNF608	611	Q9ULD9
APSKSTVYVSNLPFS	ZCRB1	6	Q8TBF4
SYSISSTLNPQAPEF	USP10	76	Q14694
FHDSKPSSSSPVAYV	USP10	346	Q14694
VNESYFKPSPTCSSI	TARBP1	581	Q13395
KPSPSSDNLYSAFTS	WNK1	2186	Q9H4A3
SVSTDPKPYIFSDAQ	ZNF831	1456	Q5JPB2
PNTDPAKYSESTSAT	ZNF275	36	Q9NSD4
YQLPSFPEPKSSTQA	SIGLEC10	641	Q96LC7
ASPDYNRTNSPSSAK	TRIP12	76	Q14669
SHFAFNSASPPKSYI	TBC1D19	331	Q8N5T2
ASNLSPDTQLYPDFT	TPRX2	246	P0DV77
SACLYSPSSQKPAAV	TTI1	101	O43156
YPESQKDTQSIDSPF	WNK3	1131	Q9BYP7
TQFSDDEYKTPLATP	VPS13D	761	Q5THJ4
NYLASKPDTPQTSGT	MYO1D	826	O94832
ARPKYFFPSTNTTAA	MYPN	721	Q86TC9